Dizziness related to GLP-1 therapy usually peaks in the first 23 weeks and resolves within 48 weeks as the body adjusts to lower calorie intake and medication effects
Multiple approaches were investigated across academic and industrial laboratories, including enteric coatings to bypass stomach acid, protease inhibitor co-formulations, nanoparticle encapsulation, mucoadhesive delivery systems, and permeation enhancers
Oxidative Stress: Concept and Some Practical Aspects
Gastroparesis is in fact a major determinant of post-prandial glucose excursions, and a cause for upper gastrointestinal symptoms
This design mirrors the lipolytic region of GH without broader growth-promoting effects
Clinical trial of a new diuretic, furosemide: comparison with hydrochlorothiazide and mercaptomerin